Search

Displaying results 3961 - 3970 of 5504 in total

Drug
Zenocutuzumab
go.drugbank.com/drugs/DB15559
ApprovedInvestigational
[L51963] It works to attenuate aberrant cancer cell growth caused by genomic rearrangements involving the neuregulin 1 gene (NRG1), which is an oncogenic driver.
Drug
Sulfacetamide
go.drugbank.com/drugs/DB00634
Approved
An anti-infective agent that is used topically to treat skin infections and orally for urinary tract infections.
Mixtures: Avar-e, Clarifoam EF
Drug
PGX-100
go.drugbank.com/drugs/DB06114
Investigational
It is a nearly nonanticoagulant heparin derivative that retains its anti-inflammatory activity. … It is developed for treatment of exacerbation of obstructive pulmonary disease (COPD) and for the prevention and treatment of cardiac ischemia reperfusion injury (following acute myocardial infarction
Drug
IDD-3
go.drugbank.com/drugs/DB05427
Experimental
It consists of mature dendritic cells loaded with lysates from melanoma tumor cell lines. … It includes Dendritophages that are dendritic cells, a type of specialized immune cells derived from the patient's own white blood cells.
Drug
CTR-107
go.drugbank.com/drugs/DB18583
Experimental
It is being investigated for the treatment of familial exudative vitreoretinopathy.
Drug
Aganirsen
go.drugbank.com/drugs/DB15369
Investigational
Aganirsen is under investigation in clinical trial NCT02947867 (Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG).
Drug
Ninvosudil
go.drugbank.com/drugs/DB08756
Investigational
It inhibits calcium sensitization to affect smooth muscle relaxation.
Drug
NS-398
go.drugbank.com/drugs/DB14060
Experimental
It was developed as part of the mechanistic study of the cyclooxygenases.
Drug
E59
go.drugbank.com/drugs/DB18372
Experimental
It was developed by Sixal Inc.
Drug
MaaT013
go.drugbank.com/drugs/DB18648
Investigational
It is being investigated for the treatment of Graft-Versus-Host Disease.